ProKidney (PROK) Stock Statistics & Valuation Metrics
Total Valuation
ProKidney has a market cap or net worth of MXN 7.36B. The enterprise value is MXN 1.31B.
- Market Cap
- MXN 7.36B
- Enterprise Value
- MXN 1.31B
Share Statistics
ProKidney has 208,926,940 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 208,926,940
- Owned by Insiders
- 46.44%
- Owned by Institutions
- 7.88%
Financial Efficiency
ProKidney’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is -53.94%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- -0.21
- Return on Invested Capital (ROIC)
- -53.94%
- Return on Capital Employed (ROCE)
- -0.54
- Revenue Per Employee
- 3,865.801
- Profits Per Employee
- -298.64K
- Employee Count
- 231
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of ProKidney is -2.27. ProKidney’s PEG ratio is 2.57.
- PE Ratio
- -2.27
- PS Ratio
- 532.33
- PB Ratio
- -0.27
- Price to FCF
- -2.73
- Price to Operating Cash Flow
- -1.71
- PEG Ratio
- 2.57
Income Statement
In the last 12 months, ProKidney had revenue of 893.00K and earned -68.99M in profits. Earnings per share was -0.52.
- Revenue
- 893.00K
- Gross Profit
- 893.00K
- Operating Income
- -165.01M
- Pretax Income
- -151.20M
- Net Income
- -68.99M
- EBITDA
- -144.62M
- Earnings Per Share (EPS)
- -0.52
Cash Flow
In the last 12 months, operating cash flow was -141.17M and capital expenditures -18.57M, giving a free cash flow of -159.73M billion.
- Operating Cash Flow
- -141.17M
- Free Cash Flow
- -159.73M
- Free Cash Flow per Share
- -0.86
Dividends & Yields
ProKidney pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -36.68%
- Earnings Yield
- -35.89%
Stock Price Statistics
- Beta
- -4.01
- 52-Week Price Change
- -56.31%
- 50-Day Moving Average
- 29.83
- 200-Day Moving Average
- 31.80
- Relative Strength Index (RSI)
- 34.82
- Average Volume (3m)
- 14.90K
Important Dates
ProKidney upcoming earnings date is Nov 16, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 10, 2026
- Next Earnings Date
- Nov 16, 2026
- Ex-Dividend Date
- ―
Financial Position
ProKidney as a current ratio of 9.13, with Debt / Equity ratio of -0.40%
- Current Ratio
- 9.13
- Quick Ratio
- 9.13
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.72
- Interest Coverage Ratio
- -41251.75
Taxes
In the past 12 months, ProKidney has paid 414.00K in taxes.
- Income Tax
- 414.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
ProKidney EV to EBITDA ratio is -2.28, with an EV/FCF ratio of -2.28.
- EV to Sales
- 445.11
- EV to EBITDA
- -2.28
- EV to Free Cash Flow
- -2.28
- EV to Operating Cash Flow
- -2.58
Balance Sheet
ProKidney has MXN 181.56M in cash and marketable securities with MXN 3.52M in debt, giving a net cash position of MXN 178.04M billion.
- Cash & Marketable Securities
- MXN 181.56M
- Total Debt
- MXN 3.52M
- Net Cash
- MXN 178.04M
- Net Cash Per Share
- MXN 0.85
- Tangible Book Value Per Share
- MXN 1.19
Margins
Gross margin is -252.57%, with operating margin of -21664.55%, and net profit margin of -10599.76%.
- Gross Margin
- -252.57%
- Operating Margin
- -21664.55%
- Pretax Margin
- -20388.39%
- Net Profit Margin
- -10599.76%
- EBITDA Margin
- -19549.14%
- EBIT Margin
- -20386.06%
Analyst Forecast
The average price target for ProKidney is MXN 116.51, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- MXN 116.51
- Price Target Upside
- 368.67% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 6
- Revenue Growth Forecast
- 39.88%
- EPS Growth Forecast
- 11.10%
Scores
- Smart Score
- 5
- AI Score
- ―
